share_log

Evaluating Cardlytics: Insights From 3 Financial Analysts

Evaluating Cardlytics: Insights From 3 Financial Analysts

評估cardlytics:來自3位金融分析師的見解
Benzinga ·  11/08 02:00
Across the recent three months, 3 analysts have shared their insights on Cardlytics (NASDAQ:CDLX), expressing a variety of opinions spanning from bullish to bearish.
最近三個月來,有3名分析師就Cardlytics(納斯達克股票代碼:CDLX)發表了自己的見解,意見各不相同,從看好到看淡不一。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天內情緒的變化,並將它們與前幾個月進行比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $4.17, along with a high estimate of $5.00 and a low estimate of $3.50. A decline of 24.18% from the prior average price target is evident in the current average.
分析師提供更深入的見解,已經確定了12個月的價格目標,顯示平均目標爲$4.17,高估爲$5.00,低估爲$3.50。 當前平均價格目標較之前下降了24.18%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
A...
通...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論